Diabetic patients who require surge...

Diabetic patients who require surgery at hand special challenges in perioperative management. Special attention must be paid to prevention and treatment of metabolic derangements. Vigilance for the progressive growth of acute complications that lead to higher rates of surgical morbidity and mortality is also critical.

Maintaining Glycemic Control

Glycemic bridle is maintained by a balance between insulin and the counterregulatory hormones glucagon, epinephrine, cortisol, and expansion hormone. Insulin stimulates glucose uptake and utilization on muscle and fat tissue. It also suppresse hepatic starch-sugar production from gluconeogenesis and glycogenolysis. Insulin obviates development of ketosis and protein breakdown. During the perioperative period, adequate insulin must be current to prevent metabolic decompensation.

Perioperative answer to Surgery and Anesthesia

Surgery and anesthesia invoke a neuroendocrine stres rejoinder with release of counter-regulatory hormones, (1) which issues in peripheral insulin resistance, increased hepatic grape-sugar production, impaired insulin secretion, and fat and protein breakdown, with potential hyperglycemia and flat ketosis in some cases. The extent of this response depends upon the complexity of the surgery and any postsurgical complications.

In addition to counter-regulatory hormone exces and relative insulin deficiency, fasting and whirl depletion contribute to metabolic decompensation. (2) Diabetic ketoacidosis fall outs infrequently in patients with archetype 2 diabetes, but hyperglycemic hyperosmolar nonketotic states are well described. The latter are characterized by dint of extreme hyperglycemia, hyperosmolarity, volume depletion, and associated changes in mental status resulting from inadequate insulin action, osmotic diuresis, fluid losse from surgery or overuse of diuretics, and body under-replacement. (3) In patients with protoplast 1 diabetes, diabetic ketoacidosis may bring to maturity in the absence of exact hyperglycemia because of inadequate insulin availability during a time of increased demand.

Hyperglycemia inhibits army defenses against infection, (4-6) including many leukocyte functions. (7-10) Hyperglycemia also impairs anguish healing because of its detrimental imports on collagen formation and resulting diminished detriment tensile strength. (11,12)

Preoperative Evaluation

In elective surgical conducts potential problems should be identified, corrected, and stabilized before surgery Preoperative evaluation includes assessment of metabolic sway and any diabetes-associated complications, including cardiovascular disease, autonomic neuropathy, and nephropathy, which could affect the surgical outcome

Asymptomatic cardiac ischemia come into views relatively often in patients with diabetes. (13) The demeanor of cardiovascular risk factors should ready a thorough evaluation. At minimum, resting electrocardiography should be performed, on the other hand a stress test is frequently justified if there is suspicion for cardiovascular disease. Cardiac autonomic neuropathy may predispose patients to perioperative hypotension, (14) in like manner the presence of resting tachycardia, orthostatic hypotension, peripheral neuropathy, and los of normal respiratory heart rate variability should be sought

Serum creatinine flushs should be measured, but they are not a sensitive indicator of early renal dysfunction, which is usually advanced before an elevation in creatinine exhibits Kidney function can be estimated according to using creatinine clearance formulas on the contrary if a high index of suspicion for renal impairment exists, a measured creatinine flat from a 24-hour urine collection is the best gauge of renal function. Diabetic patients with proteinuria or abnormal creatinine clearance have a greater risk of developing acute renal failure.

GLYCEMIC CONTROL

Establishing convenient glycemic control and correcting any other metabolic abnormalities are usually accomplished forward an outpatient basis before surgery because greatest in number patients are hospitalized just before surgery

To stabilize glycemic check in patients taking insulin, common glucose monitoring should be performed, with insulin dosages adjusted appropriately. Ideally, patients should monitor life-current glucose levels before meals, after meals, and at bedtime. Long-acting insulin (eg ultralente, glargine [Lantus]) can be discontinued single to two days before surgery and grape-sugar levels can be stabilized with a regimen of intermediate insulin (eg NPH lente) mixed with short-acting insulin (eg regular, lispro [Humalog] or aspart [Novolog]) twice daily or short-acting insulin before each meal. However, on the day before surgery long-acting insulin can be continued from beginning to end the day if the patient's command is good, particularly if the patient is using glargine. Since this newer insulin analog maintains a stable horizontal throughout the day, more experience with its use may demonstrate its safety as a basal insulin quite through the perioperative period.

Oral agents are generally discontinued before surgery Long-acting sulfonylureas (eg chlorpropamide [Diabinese]) are stopped 48 to 72 hours before surgery while short-acting sulfonylureas, other insulin secretagogues, and metformin [Glucophage] can be withheld the night before or the day of surgery No recommendations exist for discontinuation of thiazolidinediones (eg rosiglitazone [Avandia], pioglitazone [Actos]) before surgery; their extremely extended duration of action probably indicates no rationale for stopping them at all.